Arjen Brink

1.6k total citations
41 papers, 1.2k citations indexed

About

Arjen Brink is a scholar working on Otorhinolaryngology, Molecular Biology and Oncology. According to data from OpenAlex, Arjen Brink has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Otorhinolaryngology, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Arjen Brink's work include Head and Neck Cancer Studies (18 papers), Oral Health Pathology and Treatment (9 papers) and Cancer Genomics and Diagnostics (8 papers). Arjen Brink is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Oral Health Pathology and Treatment (9 papers) and Cancer Genomics and Diagnostics (8 papers). Arjen Brink collaborates with scholars based in Netherlands, United States and Italy. Arjen Brink's co-authors include Ruud H. Brakenhoff, C. René Leemans, Elisabeth Bloemena, Boudewijn J.M. Braakhuis, Robert J. Baatenburg de Jong, Sanne R. Martens‐de Kemp, Jos B. Poell, Chris J.L.M. Meijer, Michelle M. Rietbergen and Pieter J. Gaillard and has published in prestigious journals such as Nature Communications, Bioinformatics and The Journal of Immunology.

In The Last Decade

Arjen Brink

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arjen Brink Netherlands 23 470 446 372 263 192 41 1.2k
Θεόδωρος Ράμπιας Greece 19 433 0.9× 691 1.5× 291 0.8× 266 1.0× 32 0.2× 46 1.2k
Nicole Kawachi United States 14 223 0.5× 625 1.4× 323 0.9× 451 1.7× 46 0.2× 24 1.0k
Norishige Yamada Japan 21 363 0.8× 754 1.7× 47 0.1× 209 0.8× 21 0.1× 30 1.1k
Stephen M. Thirdborough United Kingdom 21 494 1.1× 452 1.0× 176 0.5× 261 1.0× 6 0.0× 31 1.3k
Li–Fu Hu Sweden 21 774 1.6× 425 1.0× 181 0.5× 242 0.9× 5 0.0× 33 1.2k
Yoshihiro Yoshitake Japan 24 636 1.4× 1.1k 2.4× 56 0.2× 241 0.9× 11 0.1× 46 2.0k
Yoshinori Suminami Japan 19 337 0.7× 521 1.2× 34 0.1× 332 1.3× 12 0.1× 41 1.2k
Risto Pirinen Finland 18 345 0.7× 686 1.5× 38 0.1× 228 0.9× 16 0.1× 31 1.1k
Meera Patturajan United States 12 560 1.2× 1.5k 3.3× 32 0.1× 148 0.6× 13 0.1× 25 1.7k
Daniel R. Vlock United States 17 447 1.0× 332 0.7× 121 0.3× 163 0.6× 5 0.0× 32 916

Countries citing papers authored by Arjen Brink

Since Specialization
Citations

This map shows the geographic impact of Arjen Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjen Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjen Brink more than expected).

Fields of papers citing papers by Arjen Brink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjen Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjen Brink. The network helps show where Arjen Brink may publish in the future.

Co-authorship network of co-authors of Arjen Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Arjen Brink. A scholar is included among the top collaborators of Arjen Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjen Brink. Arjen Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wils, Leon J., Jos B. Poell, Arjen Brink, et al.. (2025). New insights into the genetic progression of cancer through longitudinal analysis of oral lesions. The Journal of Pathology. 267(2). 155–167.
2.
Nauta, Irene H., K Grünewald, Arjen Brink, et al.. (2024). Hallmarks of a genomically distinct subclass of head and neck cancer. Nature Communications. 15(1). 9060–9060. 7 indexed citations
3.
Poell, Jos B., Arjen Brink, Reinout H. de Roest, et al.. (2024). Intratumor genetic heterogeneity and head and neck cancer relapse. Radiotherapy and Oncology. 191. 110087–110087. 5 indexed citations
4.
Brink, Arjen, et al.. (2023). In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region. The CRISPR Journal. 6(2). 127–139. 12 indexed citations
5.
Wils, Leon J., Jos B. Poell, Arjen Brink, et al.. (2022). Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. Clinical Cancer Research. 29(3). 602–613. 26 indexed citations
6.
Nauta, Irene H., Daniëlle A.M. Heideman, Arjen Brink, et al.. (2021). The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. International Journal of Cancer. 149(2). 420–430. 50 indexed citations
7.
Roest, Reinout H. de, Steven W. Mes, Jos B. Poell, et al.. (2019). Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy. Clinical Cancer Research. 25(23). 7256–7265. 17 indexed citations
8.
Buijze, Marijke, Martin A. Rooimans, Sanne R. Martens‐de Kemp, et al.. (2019). Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death. Oncogenesis. 8(7). 38–38. 46 indexed citations
9.
Poell, Jos B., Marijke Buijze, Arjen Brink, et al.. (2019). Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. Oral Oncology. 98. 53–61. 21 indexed citations
10.
Brink, Arjen, Marijke Buijze, Marijke Stigter‐van Walsum, et al.. (2018). Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining. Molecular Cancer Research. 17(1). 120–130. 24 indexed citations
11.
Kemp, Sanne R. Martens‐de, Arjen Brink, Renée X. de Menezes, et al.. (2016). The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics. Molecular Cancer Therapeutics. 16(3). 540–550. 22 indexed citations
12.
Velleuer, Eunike, Ralf Dietrich, Arjen Brink, et al.. (2015). Noninvasive Molecular Screening for Oral Precancer in Fanconi Anemia Patients. Cancer Prevention Research. 8(11). 1102–1111. 15 indexed citations
13.
Stoepker, Chantal, Najim Ameziane, Petra van der Lelij, et al.. (2015). Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer. Cancer Research. 75(17). 3543–3553. 25 indexed citations
14.
Maaker, Michiel de, Arjen Brink, Boudewijn J.M. Braakhuis, et al.. (2013). Molecular screening of oral precancer. Oral Oncology. 49(12). 1129–1135. 54 indexed citations
15.
Brink, Arjen, Mélanie Nguyen, C. René Leemans, et al.. (2012). Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers. Head & Neck. 35(4). 568–574. 14 indexed citations
16.
Brink, Arjen, Petra B. van den Doel, Zeng B. Zhu, et al.. (2010). Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions. Gene Therapy. 17(12). 1517–1524. 8 indexed citations
17.
Braakhuis, Boudewijn J.M., Arjen Brink, Mark A. M. Broeckaert, et al.. (2008). Comparative evaluation of genetic assays to identify oral pre‐cancerous fields. Journal of Oral Pathology and Medicine. 37(10). 599–606. 28 indexed citations
18.
Meij, Pauline, Elisabeth Bloemena, Arjen Brink, et al.. (2001). Functional CD4+ and CD8+ T-Cell Responses Induced by Autologous Mitomycin C Treated Epstein–Barr Virus Transformed Lymphoblastoid Cell Lines. Cellular Immunology. 208(1). 25–33. 6 indexed citations
19.
Soede, Ron D. M., et al.. (1999). LFA-1 to LFA-1 Signals Involve ζ-Associated Protein-70 (ZAP-70) Tyrosine Kinase: Relevance for Invasion and Migration of a T Cell Hybridoma. The Journal of Immunology. 163(8). 4253–4261. 30 indexed citations
20.
Meij, Pauline, Marcel B. H. J. Vervoort, Jamil Aarbiou, et al.. (1999). Restricted Low‐Level Human Antibody Responses against Epstein‐Barr Virus (EBV)–Encoded Latent Membrane Protein 1 in a Subgroup of Patients with EBV‐Associated Diseases. The Journal of Infectious Diseases. 179(5). 1108–1115. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Θεόδωρος Ράμπιας Breakdown of academic impact, for papers by Nicole Kawachi Breakdown of academic impact, for papers by Norishige Yamada Breakdown of academic impact, for papers by Stephen M. Thirdborough Breakdown of academic impact, for papers by Li–Fu Hu Breakdown of academic impact, for papers by Yoshihiro Yoshitake Breakdown of academic impact, for papers by Yoshinori Suminami Breakdown of academic impact, for papers by Risto Pirinen Breakdown of academic impact, for papers by Meera Patturajan Breakdown of academic impact, for papers by Daniel R. Vlock
Rankless by CCL
2026